New PBS listings announced

June PBS listings include medications for COPD, type 2 diabetes and ulcerative colitis, federal health minister Greg Hunt has announced.

More than half a million Australians with moderate to severe chronic obstructive pulmonary disease (COPD) will potentially benefit from the listing of a triple therapy inhaler, the first such treatment to be subsidised.

The once-daily inhaler Trelegy Ellipta (GSK) contains an inhaled corticosteroid (fluticasone furoate), the long-acting muscarinic antagonist umeclidinium, and the long acting beta2-adrenergic agonist,